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Preimplantation Genetic Diagnosis (PGD) is a form of prenatal diagnosis that is performed on early embryos created by in 
vitro fertilization (IVF) to discover single gene mutations or chromosome abnormalities. The latter is known as 
Preimplantation Genetic Screening (PGS) since it is a non-invasive, rapid and sufficiently low cost procedure. 
It has been seen that in many cases IVF failure is due to aneuploidy, which causes the embryo not to be able to implant 
and develop. For this reason, PGS is becoming a rutinary technique in many clinics to prioritise embryos for transfer, 
which leads to improved implantation rates and decreased number of miscarriages. 
Nowadays, the widely used PGS technique to look for aneuploidies is Array-CGH but quicker, cheaper and more efficient 
techniques are needed. New techniques such as Next-generation Sequencing (NGS) are being developed and validated for 
its application.  
Biopsy stage Advantages Limitations 
Polar Bodies (Day 0) - Less invasive 
- No need for vitrification 
- Only mother’s material is analyzed 
- Not many genetic material (single cells) 
Cleavage Stage (Day 3) - No need for vitrification -Invasive technique         can harm embryos 
- Not many genetic material (single cells) 
Blastocyst Stage (Day 5) -Doesn’t harm embryos 
- More genetic material 
(multiple cells) 
- Need for vitrification 
The first step in PGS is embryo biopsy. Genetic material from the oocyte or embryo must 
be obtained to analyse it. Embryo biopsy can be performed at different stages and every 
stage has its advantages and limitations making it a better or worst method depending 
on the case. After the embryo’s biopsy, the cells are subjected to lysis and the genetic 
material is analyzed.  
PGS TECHNIQUES 
There are different techniques used in PGS to look for aneuploidies. 
- FISH - SNP microarray 
- CGH - Array CGH                     Widely used technique  
- Real-time quantitative PCR - Next generation sequencing (NGS) 
  
WHOLE GENOME AMPLIFICATION (WGA) 
WGA is the most critical step in NGS since the genome has to be amplified 
from a single cell or a few cells. There are different methodologies for WGA 
based on:   
PCR methods: degenerated oligonucleotides that act as primers are 
used to amplify the entire genome in the same PCR reaction.   
OBJECTIVES 
METHODOLOGY 
This project is a bibliographical review. In order to find 
articles and reviews related to the topic, a search is done 
using pubmed and key words like “Preimplantation genetic 
diagnosis”, “Aneuploidy screening” and “Next-generation 
sequencing” within an interval of five years. 
 
- Discuss the need for PGS.  
- Compare the techniques used nowadays for PGS to NGS 
- Review different methodologies for NGS techniques  
- Evaluate NGS’s current situation. 
 
NGS techniques are a range of different sequencing techniques that allow millions of small 
fragments of DNA to be sequenced at once. The most commonly used NGS platforms are 
LifeTechnologies’ Ion Torrent Personal Genome Machine (PGM) and Illumina’s MiSeq and HiSeq 
platforms.   
Nowadays, NGS techniques are being validated for their implemantiation in PGS to look for 
aneuploidies and improve the clinical outcome of embryos in IVF procedures. 
-PGS is important due to the high rates of aneuploid embryos seen in patients 
undergoing IVF procedures. When the embryos are screened, euploid embryos can 
be prioritised for transfer and higher implantation rates are seen, leading to more 
successful pregnancies. 
-Old PGS methods, like FISH, could only evaluate some chromosomes at the same 
time. Other newer methods allow 24-chromosome analysis but are expensive and too 
slow to allow fresh transfer of embryos after biopsy at blastocyst stage. Next-
generation Sequencing is a faster, cheaper and accurate method for PGS.  
-There are many NGS techniques with different methodologies. Both semiconductor 
sequencing and fluorescent sequencing are good techniques that allow sequencing of 
millions of small fragments of DNA and can be used to detect aneuploid embryos. 
-Currently, NGS techniques are being validated and all the studies carried out 
conclude that it is a reliable technique that will most likely become the widely used 
technique for PGS in the near future.    
NGS techniques are faster (<15 hours, compared to >24h with Array-CGH), cheaper (2/3 of 
Array-CGH’s cost) and as accurate as Array-CGH. 
Multiple Displacement Amplification (MDA): random primers and an 
isothermal DNA polymerase are used to amplify the entire genome. 
In order to validate NGS, studies can: 
compare NGS to previous methodologies in order to know NGS’s sensitivity and specificity,  
use NGS to study the clinical outcome of the embryos undergoing PGS. 
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